CLINICAL_TRIALS
ClinicalTrials.gov record update
Clinical Study of Core Blood-derived Anti-CD19 IL-10/IL15 CAR-NK in the Treatment of Refractory/Relapsed Autoimmune Diseases
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06614270
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:44.234459+00:00
- Published At
- 2025-12-29T00:00:00+00:00
- Record Updated At
- 2025-12-29
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Systemic Sclerosis (SSc)", "ANCA Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myopathy (IIM)", "Sjogren\u0026#39;s Syndrome", "Antiphospholipid Syndrome", "Systemic Lupus Erythematosus"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-29"- protocolSection.identificationModule.nctId
"NCT06614270"- protocolSection.identificationModule.officialTitle
"Clinical Study of Core Blood-derived Anti-CD19 IL-10/IL15 CAR-NK in the Treatment of Refractory/Relapsed Autoimmune Diseases"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.